Berberine

What it is

Berberine is a natural isoquinoline alkaloid extracted from the roots, rhizomes, and stem bark of medicinal plants such as Berberis aristata, Berberis vulgaris, and Coptis chinensis. In dietary supplements, it is standardly supplied as berberine hydrochloride (HCl), a crystalline yellow powder. It acts intracellularly as an activator of adenosine monophosphate-activated protein kinase (AMPK), a master metabolic regulator governing glucose uptake, lipid oxidation, and cellular energy homeostasis.

Also known as: Berberine HCl, Berberis aristata extract

What it does

• Supports healthy blood glucose regulation and insulin sensitivity already within normal limits.
• Helps maintain healthy serum lipid levels including cholesterol and triglycerides.
• Activates cellular AMPK pathways to promote metabolic energy balance and gut barrier function.

Amplified by probiotics

Berberine exhibits low oral bioavailability (~5%), meaning the majority remains within the gut intestinal lumen where it directly interacts with the gut microbiota. Commensal probiotic bacteria convert berberine into dihydroberberine via bacterial nitroreductase enzymes, a reduced form that displays up to five-fold higher intestinal absorption. Once absorbed across the enterocyte membrane, dihydroberberine oxidizes back into active berberine in intestinal tissue. Furthermore, probiotic short-chain fatty acids (SCFAs) act synergistically with berberine to strengthen tight junctions, lower mucosal inflammatory markers, and modulate gut peptide secretion (such as GLP-1) for enhanced metabolic regulation.

Typical dose

500–1500 mg/day (split in 2–3 doses)

The evidence

Multiple meta-analyses of randomized clinical trials confirm that berberine supplementation significantly improves fasting glucose, HbA1c, and lipid profiles in adults with metabolic risk factors (Dong 2012, Evid Based Complement Alternat Med). Clinical studies demonstrate metabolic efficacy comparable to standard oral agents, alongside favorable safety profiles (Zhang 2008, J Clin Endocrinol Metab).

1. Dong H, et al. Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis. Evid Based Complement Alternat Med. 2012;2012:591654. PubMed ↗
2. Zhang Y, et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab. 2008;93(7):2559-2565. PubMed ↗

Safety & who should check first

Well tolerated at recommended doses; temporary mild GI cramping or constipation may occur. Not recommended during pregnancy or breastfeeding due to potential uterine stimulation and bilirubin displacement.